Successfully navigating early payer scientific advice whether through Joint Scientific Consultations (JSCs), national HTA channels, or informal advisory boards, demands strategic planning and strong positioning. The BRAVE approach from Remap Consulting helps manufacturers prepare by focusing on five essential behaviors that improve readiness and outcomes.
Why Implement the BRAVE Approach?
- Mitigate uncertainty around trial design and payer expectations
- Enhance the quality and impact of advice obtained
- Create alignment across internal teams
- Increase the likelihood of favorable pricing and reimbursement outcomes